Friedensohn, L., Levin, D., Fadlon-Derai, M., Gershovitz, L., Fink, N., Glassberg, E., & Gordon, B. (2022). Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel. JAMA. https://doi.org/10.1001/jama.2022.4425

One dose of Pfizer or Oxford jab reduces Covid infection rate by 65% – study. (2021, April 22). The Guardian. http://www.theguardian.com/society/2021/apr/23/one-dose-of-pfizer-or-oxford-jab-reduces-covid-infection-rate-by-65-study

Lovett, S. (2021, November 15). UK threw away 600,000 vaccine doses after they passed expiry date. The Independent. https://www.independent.co.uk/news/health/covid-vaccine-doses-astrazeneca-donations-uk-b1958000.html

Gutman, R. (2021, October 28). Is Moderna Really Better Than Pfizer—Or Is It Just a Higher Dose? The Atlantic. https://www.theatlantic.com/health/archive/2021/10/pfizer-moderna-dose-which-vaccine-best/620501/

Dolgin, E. (2021). Omicron is supercharging the COVID vaccine booster debate. Nature. https://doi.org/10.1038/d41586-021-03592-2

Cortellessa, E., & Wolfe, L. (2021, October 15). Why Is the U.S. Hoarding Hundreds of Millions of COVID Vaccines? Washington Monthly - Politics. https://washingtonmonthly.com/2021/10/15/why-is-the-u-s-hoarding-hundreds-of-millions-of-covid-vaccines/

Zimmer, C. (2021, September 21). An extra J. & J. shot substantially boosts protection against Covid, the company reports. The New York Times. https://www.nytimes.com/2021/09/21/health/johnson-and-johnson-shot.html

Gye, H. (2021, November 29). All adults to be offered booster jabs after 3 months, and over-12s to get second doses. Inews.Co.Uk. https://inews.co.uk/news/politics/covid-booster-jabs-to-be-offered-all-adults-after-3-months-and-over-12s-second-doses-1325151

Community-Based Research Shows More People Exposed to COVID-19 Virus Than Previously Known: Institute for Policy Research - Northwestern University. (2021, April 13). https://www.ipr.northwestern.edu/news/2021/scan-study-preliminary-findings-of-levels-of-protective-immunity-sars-cov-2.html

Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948

Lipsitch, M., Krammer, F., Regev-Yochay, G., Lustig, Y., & Balicer, R. D. (2021). SARS-CoV-2 breakthrough infections in vaccinated individuals: Measurement, causes and impact. Nature Reviews Immunology, 1–9. https://doi.org/10.1038/s41577-021-00662-4

Morris, J. (2021, August 17). Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated? Covid Data Science. https://www.covid-datascience.com/post/israeli-data-how-can-efficacy-vs-severe-disease-be-strong-when-60-of-hospitalized-are-vaccinated

Eric Topol. (2021, June 9). Despite increasing incentives, the US vaccination campaign is really struggling. Notably, the top 5 states are approaching 60% total population fully vaccinated which should provide strong protection vs the delta variant. A different story for the bottom 5 states @OurWorldInData https://t.co/boqk3Khhuc [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1402413221667954690

Dr Philip Lee. (2021, March 17). It’s been 100 days since the first dose of the SARS2-CoV vaccine was given in the UK, and 24.8 million people have received their first dose since. That is pretty amazing. [Tweet]. @drphiliplee1. https://twitter.com/drphiliplee1/status/1372162781823303681

Nicolas Berrod. (2021, April 9). Population majeure vaccinée avec au moins une dose (une seule dose/deux doses), au 8 avril: -Tous âges: 19,3% (12,6%/6,6%) -moins de 75 ans: 13,3% (10,5%/2,8%) -75 ans ou plus: 62,5% (28,2%/34,2%) Les pourcentages sont arrondis. #Covid19 https://t.co/EUsyr9LSo8 [Tweet]. @nicolasberrod. https://twitter.com/nicolasberrod/status/1380586797542039554

simine vazire. (2021, August 27). Great to see numbers continuing to climb; seems like they’re climbing maybe as fast as supply allows! [Tweet]. @siminevazire. https://twitter.com/siminevazire/status/1431187367834972162

Michael McCarthy. (2021, August 27). #COVD19 vax rates are still increasing in Australia. The over 70s are approaching 90% with first doses. The red line is the rate for all people >=16. That should reach 60% soon. Https://t.co/NH3Q7jumgT [Tweet]. @mickresearch. https://twitter.com/mickresearch/status/1431185640884826112

Katherine J. Wu, Ph.D. (2021, December 29). I wrote (last week!) about the future of boosting—How many more shots will we need? Will they all contain the same ingredients? Ultimately, it depends on our immune systems, how the virus looks, and how much of the virus is around. 1/3 https://t.co/bJKYyriE9a [Tweet]. @KatherineJWu. https://twitter.com/KatherineJWu/status/1476249881073303552

Lawrence Gilder on Twitter. (n.d.). Twitter. Retrieved 15 November 2021, from https://twitter.com/LawrenceGilder/status/1449030844132298764

Richard. (2021, October 17). @fascinatorfun Letter to parents sent to me by a friend today … https://t.co/Ivn93WLD9t [Tweet]. @dikt54. https://twitter.com/dikt54/status/1449763622020866055

Getting a Vaccine. (n.d.). Retrieved 31 March 2022, from http://www.bccdc.ca/health-info/diseases-conditions/covid-19/covid-19-vaccine/getting-a-vaccine#under12

Dr. Deepti Gurdasani. (2022, March 1). New study out yesterday suggesting that vaccine efficacy with current dose for 5-11 yr olds likely wanes quickly. Especially against infection, but also against hospitalisation, although protection against severe disease is higher. Seems to be closely linked to vaccine dose🧵 https://t.co/NojLODF1ED [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1498580243665367040

Trevor Bedford on Twitter. (n.d.). Twitter. Retrieved 29 March 2022, from https://twitter.com/trvrb/status/1466076761427304453

ReconfigBehSci on Twitter: ‘RT @PeterHotez: I’m trying to reconcile Pfizer’s optimistic statements about 3rd dose protection against omicron https://t.co/mIWDowkDW6 v…’ / Twitter. (n.d.). Retrieved 29 March 2022, from https://twitter.com/SciBeh/status/1468568425308078088

Corbevax: All About India’s First Protein Sub-Unit Covid Vaccine to be Given to 12-14 Age Group From Today. (2022, March 16). News18. https://www.news18.com/news/india/corbevax-all-about-indias-first-protein-sub-unit-covid-vaccine-to-be-given-to-12-14-age-group-from-today-4874345.html

Wu, K. J. (2021, December 1). What J&J Can Still Teach Us. The Atlantic. https://www.theatlantic.com/science/archive/2021/12/vaccine-durability-annual-covid-boosters/620863/

Wu, K. J. (2021, December 29). Our Relationship With COVID Vaccines Is Just Getting Started. The Atlantic. https://www.theatlantic.com/science/archive/2021/12/how-many-covid-19-booster-shots/621132/

Yang, M. (2022, February 28). Pfizer vaccine significantly less effective in children ages five to 11, study shows. The Guardian. https://www.theguardian.com/society/2022/feb/28/pfizer-vaccine-less-effective-children-ages-five-to-11-data

Freja Kirsebom. (2022, January 7). Today we publish our latest analysis where we stratify by age to investigate vaccine effectiveness (VE) against Omicron in adults aged 65 years and older in England. Https://t.co/y73uto6kll 1/14 [Tweet]. @freja_kirsebom. https://twitter.com/freja_kirsebom/status/1479528228079509516

Hause, A. M. (2021). COVID-19 Vaccine Safety in Children Aged 5–11 Years—United States, November 3–December 19, 2021. MMWR. Morbidity and Mortality Weekly Report, 70. https://doi.org/10.15585/mmwr.mm705152a1

Mahase, E. (2022). Covid-19: What do we know about omicron sublineages? BMJ, 376, o358. https://doi.org/10.1136/bmj.o358

Peña-Hernández, M. A., Klein, J., Malik, A. A., Coppi, A., Kalinich, C., Vogels, C. B. F., Silva, J., Initiative, Y. S.-C.-2 G. S., Peaper, D. R., Landry, M.-L., Wilen, C., Grubaugh, N. D., Schulz, W., Omer, S. B., & Iwasaki, A. (2022). Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals (p. 2021.12.28.21268460). medRxiv. https://doi.org/10.1101/2021.12.28.21268460

COVID-19 vaccine doses donated to COVAX. (n.d.). Our World in Data. Retrieved February 10, 2022, from https://ourworldindata.org/grapher/covax-donations

Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Gameiro, S. F., Tang, S., … Xing, Z. (2022). Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell, S0092867422001453. https://doi.org/10.1016/j.cell.2022.02.005

Chatterjee, D., Tauzin, A., Marchitto, L., Gong, S. Y., Boutin, M., Bourassa, C., Beaudoin-Bussières, G., Bo, Y., Ding, S., Laumaea, A., Vézina, D., Perreault, J., Gokool, L., Morrisseau, C., Arlotto, P., Fournier, É., Guilbault, A., Delisle, B., Levade, I., … Finzi, A. (2022). SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2022.110429

Hall, V. G., Ferreira, V. H., Wood, H., Ierullo, M., Majchrzak-Kita, B., Manguiat, K., Robinson, A., Kulasingam, V., Humar, A., & Kumar, D. (2022). Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nature Immunology, 1–6. https://doi.org/10.1038/s41590-021-01126-6

Vanshylla, K., Tober-Lau, P., Gruell, H., Muenn, F., Eggeling, R., Pfeifer, N., Le, N. H., Landgraf, I., Kurth, F., Sander, L. E., & Klein, F. (2022). Durability of Omicron-neutralizing serum activity following mRNA booster immunization in elderly individuals (p. 2022.02.02.22270302). medRxiv. https://doi.org/10.1101/2022.02.02.22270302

Moderna wins full approval for its Covid-19 vaccine, as Novavax seeks authorization for its version. (2022, January 31). STAT. https://www.statnews.com/2022/01/31/and-then-there-were-2-fda-gives-full-approval-to-modernas-covid-19-vaccine/

Pajon, R., Doria-Rose, N. A., Shen, X., Schmidt, S. D., O’Dell, S., McDanal, C., Feng, W., Tong, J., Eaton, A., Maglinao, M., Tang, H., Manning, K. E., Edara, V.-V., Lai, L., Ellis, M., Moore, K. M., Floyd, K., Foster, S. L., Posavad, C. M., … Montefiori, D. C. (2022). SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMc2119912

Early data indicate vaccines still protect against Omicron’s sister variant, BA.2. (2022, January 28). STAT. https://www.statnews.com/2022/01/28/early-data-indicate-vaccines-still-protect-against-omicrons-sister-variant-ba-2/

Taylor, L. (2022). Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine. BMJ, 376, o210. https://doi.org/10.1136/bmj.o210

Reuters. (2022, January 25). Israel mulls offering 4th COVID vaccine dose to all adults. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/israel-mulls-offering-4th-covid-vaccine-dose-all-adults-2022-01-25/

Dr. Melvin Sanicas, #GetVaccinated. (2022, January 24). Smart people change their minds. They reconsider things they thought they’d already figure out when offered compelling data contradicting their previous understanding. Last week we saw the Swiss data. This is from #USA. #scicomm #dataviz #VaccinesSaveLives (h/t @OurWorldInData) https://t.co/Z5ONLNXr2u [Tweet]. @Vaccinologist. https://twitter.com/Vaccinologist/status/1485704680550412303

Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2021). Risk of myocarditis following sequential COVID-19 vaccinations by age and sex (p. 2021.12.23.21268276). medRxiv. https://doi.org/10.1101/2021.12.23.21268276

Blackwell, T. (2022, January 17). Vaccine mandates increased uptake of COVID shots by almost 70%, Canadian study finds. National Post. https://nationalpost.com/news/canada/vaccine-mandates-increased-uptake-of-covid-shots-by-almost-70-canadian-study-finds

Dolgin, E. (2022). Omicron thwarts some of the world’s most-used COVID vaccines. Nature. https://doi.org/10.1038/d41586-022-00079-6

Dave, D., Friedson, A. I., Hansen, B., & Sabia, J. J. (2021). Association Between Statewide COVID-19 Lottery Announcements and Vaccinations. JAMA Health Forum, 2(10), e213117. https://doi.org/10.1001/jamahealthforum.2021.3117

•. (n.d.). NYC ER Doc Breaks Down How Omicron Affects the Boosted, Vaxxed and Unvaccinated. NBC New York. Retrieved January 13, 2022, from https://www.nbcnewyork.com/news/coronavirus/nyc-er-doc-breaks-down-how-omicron-affects-the-boosted-vaxxed-and-unvaccinated/3468742/

Olson, S. M., Newhams, M. M., Halasa, N. B., Price, A. M., Boom, J. A., Sahni, L. C., Pannaraj, P. S., Irby, K., Walker, T. C., Schwartz, S. P., Maddux, A. B., Mack, E. H., Bradford, T. T., Schuster, J. E., Nofziger, R. A., Cameron, M. A., Chiotos, K., Cullimore, M. L., Gertz, S. J., … Randolph, A. G. (2022). Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2117995

Omicron largely evades immunity from past infection or two vaccine doses | Imperial News | Imperial College London. (n.d.). Imperial News. Retrieved January 12, 2022, from https://www.imperial.ac.uk/news/232698/omicron-largely-evades-immunity-from-past/

Zambrano, L. D. (2022). Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years—United States, July–December 2021. MMWR. Morbidity and Mortality Weekly Report, 71. https://doi.org/10.15585/mmwr.mm7102e1

Iacobucci, G. (2022). Covid-19: Fourth vaccine doses—who needs them and why? BMJ, 376, o30. https://doi.org/10.1136/bmj.o30

Richterman, A., Scott, J., & Cevik, M. (2021). Covid-19 vaccines, immunity, and boosters. BMJ, 375, n3105. https://doi.org/10.1136/bmj.n3105

Reuters. (2021, December 20). Moderna says booster produces strong antibody response to Omicron. The Guardian. https://www.theguardian.com/world/2021/dec/20/moderna-booster-strong-antibody-response-omicron-covid-vaccine-variant

Eric Topol. (2021, December 14). The bottom line that is worth a few seconds for you to read https://t.co/nOzyaxO9od [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1470767386810884100

Mallapaty, S., Callaway, E., Kozlov, M., Ledford, H., Pickrell, J., & Van Noorden, R. (2021). How COVID vaccines shaped 2021 in eight powerful charts. Nature. https://doi.org/10.1038/d41586-021-03686-x

Simon, M. A., Luginbuhl, R. D., & Parker, R. (2021). Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After (p. 2021.11.17.21263608). https://doi.org/10.1101/2021.11.17.21263608

New Study Finds Vaccine Dose Timing Reduces Risk of Long-COVID in Unvaccinated Patients. (2021, December 15). Arcadia.Io. https://arcadia.io/press-release-vaccine-dose-timing-reduces-long-covid-risk/

Altmann, D. M., & Boyton, R. J. (2021). SARS-Cov-2 immune waning and reinfection in care-home settings. The Lancet. Healthy Longevity, 2(12), e776–e777. https://doi.org/10.1016/S2666-7568(21)00276-2

Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A. C., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine, 1–13. https://doi.org/10.1038/s41591-021-01630-0

Mills, M. C., & Rüttenauer, T. (2021). The effect of mandatory COVID-19 certificates on vaccine uptake: Synthetic-control modelling of six countries. The Lancet Public Health, 0(0). https://doi.org/10.1016/S2468-2667(21)00273-5

Visual, F. T., & team, D. J. (n.d.). Covid-19 vaccine tracker: The global race to vaccinate. Retrieved 13 December 2021, from https://ig.ft.com/coronavirus-vaccine-tracker/

Ayoubkhani, D., Bermingham, C., Pouwels, K. B., Glickman, M., Nafilyan, V., Zaccardi, F., Khunti, K., Alwan, N. A., & Walker, A. S. (2021). Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: Community-based cohort study (p. 2021.12.09.21267516). https://doi.org/10.1101/2021.12.09.21267516

Mahase, E. (2021). Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds. BMJ, 375, n3011. https://doi.org/10.1136/bmj.n3011

News updates from October 25: WHO calls emergency meeting on new Covid variant, German confidence dives, UK migration drops. (2021, November 25). Financial Times.

Expert reaction to study looking at COVID infection risk as time increases after second Pfizer vaccine dose in Israel | Science Media Centre. (n.d.). Retrieved 29 November 2021, from https://www.sciencemediacentre.org/expert-reaction-to-study-looking-at-covid-infection-risk-as-time-increases-after-second-pfizer-vaccine-dose-in-israel/

Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Murugesan, D. R., Desiraju, B. K., Kshetrapal, P., Pandey, R., Scaria, V., Malik, P. K., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00680-0

Stephen Reicher. (2021, November 26). 55.1% of the worlds population has had one dose of Covid vaccine. 29% in South Africa 10.1% in Africa as a whole Only 6% of Africans are fully vaccinated So is it any surprise new variants are arising from Africa? What doesn’t go around (as vaccine) Comes around (as Covid). Https://t.co/0X0vZ6flmc [Tweet]. @ReicherStephen. https://twitter.com/ReicherStephen/status/1464202267196858380

Chise 🧬🧫🦠💉🔜 MFF. (2021, November 21). If you’re wondering what difference a booster makes. Https://t.co/858ZpST7Kh [Tweet]. @sailorrooscout. https://twitter.com/sailorrooscout/status/1462441020948459525

Reardon, S. (2021). Cuba’s bet on home-grown COVID vaccines is paying off. Nature. https://doi.org/10.1038/d41586-021-03470-x

Holder, Josh. ‘Tracking Coronavirus Vaccinations Around the World’. The New York Times, 29 January 2021, sec. World. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html.

Breen, Liz, and Sarah Schiffling. ‘The UK’s Speedy COVID-19 Vaccine Rollout: Surprise Success or Planned Perfection?’ The Conversation. Accessed 15 November 2021. http://theconversation.com/the-uks-speedy-covid-19-vaccine-rollout-surprise-success-or-planned-perfection-155922.

Measuring vaccine efficacy from population data. (n.d.). The Centre for Evidence-Based Medicine. Retrieved 29 October 2021, from https://www.cebm.net/covid-19/measuring-vaccine-efficacy-from-population-data/

Covering COVID-19 vaccine boosters: 4 tips and a timeline. (n.d.). Retrieved October 25, 2021, from https://journalistsresource.org/home/covid-19-boosters-tip-sheet/

Cassidy, C. (2021, September 24). ‘Absolutely madness’: Melbourne teenagers reveal they are behind leading Covid tracking website. The Guardian. https://www.theguardian.com/australia-news/2021/sep/24/absolutely-madness-melbourne-teenagers-reveal-they-are-behind-leading-covid-tracking-website